🔗 Share this article

An underground market for unapproved slimming medications is propelled by social media fitness personalities and sellers on messaging platforms, based on recent findings.

Investigational Drug Acquiring Traction Via Social Media

The experimental drug, which remains in clinical trials, is being promoted by online personalities for its alleged fat-burning properties. Followers are urged to contact these profiles privately for source information, while also obtaining promotional offers.

Active Commerce on Social Networks

Separately, a robust market exists on messaging services, where communities with thousands of participants share “before and after” photos, administration instructions and assertions of next-day UK delivery. Vendors market the drug there before directing buyers to WhatsApp for purchases.

Learning About The Experimental Drug

Retatrutide is an experimental injectable created by US drugmaker Eli Lilly. The treatment targets three intestinal hormones – glucagon-like peptide-1, glucose-dependent insulinotropic polypeptide and pancreatic hormone. Preliminary studies suggest it could help patients reduce up to 25% of their total weight. Nicknamed the “triple G”, the drug is being promoted digitally as the next Ozempic.

Healthcare Professionals Express Worries

However, doctors and pharmacists have cautions that the sale of what remains an unlicensed medication in the UK is a cause for concern and could lead to users injecting products of unknown origin.

Some experts said the popularity for retatrutide could be linked to the rising price of approved slimming treatments such as Mounjaro.

Legal Position and Enforcement

Selling retatrutide on TikTok or messaging apps is prohibited in the United Kingdom, as it is an unlicensed drug that must not be marketed or distributed for personal consumption under the Human Medicines Regulations 2012.

Several content creators try to circumvent the rules by referring to the drug as a “research chemical” or citing it as “not for human consumption”. The substance is not a restricted drug, but advertising and supply can still breach medicines, advertising, and consumer laws, risking fines, legal action or prison.

Platform Response and Content Elimination

Based on TikTok, the service has removed violative material and banned related hashtags and search suggestions. The organization said it was committed to keeping the service safe and investing in strengthening enforcement strategies.

Digital Trading Operations

Research also found groups with up to nine thousand participants marketing retatrutide using Telegram's integrated discovery tool, which functions like a public directory. Entering “retatrutide” instantly displays channels with numerous of members, filled with images of weight loss, positive reviews and step-by-step instructions for preparing or injecting at home.

Within minutes of joining one group, a seller shared WhatsApp details, where most purchases take place. The seller sent an instruction manual and promised delivery within 48 hours. When questioned whether the substance was genuine, one vendor said: “You can’t be sure.” Another shared a photo of a alleged laboratory certificate. None asked about weight, health issues or previous experience.

Item Details and Costs

Inside these groups, posts show dark colored packages with Royal Mail labels, stating to include new batches. One communication stated: “It took eight of us to load them this morning.”

Customers can choose between dry substance containers, prepared at home with purified liquid, or pre-filled injectors usually priced at 160 pounds for 20 milligrams. When asked how much time a pen should last, vendors give contradictory answers varying between a few weeks to “depends on your body”.

Platform Moderation and Safety Measures

A spokesperson for the messaging service said it regularly moderated dangerous material on its service including material that encouraged the “misuse of controlled medications”. The company noted that it removed “millions of pieces of harmful content each day”.

Healthcare Expert Cautions

“People are administering materials they cannot confirm. Even if the science behind this drug is valid, these online products may not contain what they advertise,” stated Jason Murphy, the director of pharmacy at a pharmacy service.

Dr Crystal Wyllie of an online medical service linked the increase in interest to recent price rises for authorized weight-loss medications such as Mounjaro. “With costs increasing, patients are turning to online platforms. But fake treatments are extremely dangerous. You can’t be certain what’s contained or whether the conditions they were made in was clean,” she said.

Her team has previously encountered individuals injured by self-injection from unconfirmed suppliers. “We understand the disappointment, but purchasing from Telegram or communication platforms is gambling with your well-being,” said Wyllie. “These substances could be contaminated or improperly measured.”

Producer Position

A spokesperson from the pharmaceutical company said retatrutide was in phase 3 clinical trials and had not been reviewed or approved by any government authority anywhere in the world. “Therefore at this point no one can market [it] for human use,” they explained, noting that any product “misleadingly claiming itself as a Lilly investigational substance not yet authorized … may expose users to potentially significant medical dangers”.